Most common cause of death in Rheumatoid Arthritis?
Most common cause of death in adults with PDA is?
Essential criteria for TOF includes all except ?
Buerger's disease affects all except -
A young female presents with chest pain not associated with exercise. Auscultation reveals multiple ejection clicks with a murmur. The most important investigation for diagnosis is:
Obstruction in pulmonary stenosis may occur at the following sites ___________
Which lipid parameter is most useful for cardiovascular risk stratification in hypertensive patients?
Which of the following is NOT true about Erythrocyanosis?
True about Ebstein anomaly is ?
Which of the following represents a desired lipid parameter for cardiovascular risk control in hypertension?
Explanation: ***Ischemic heart disease*** - Patients with **rheumatoid arthritis (RA)** have a significantly increased risk of developing **cardiovascular diseases**, including ischemic heart disease. [1] - This heightened risk is due to chronic systemic inflammation, accelerated atherosclerosis, and potential side effects of RA treatments contributing to **endothelial dysfunction**. [1] *Hepatic failure* - While certain medications used to treat RA, such as **methotrexate**, can cause liver toxicity, hepatic failure is not the most common cause of death in RA patients. [2] - Regular **liver enzyme monitoring** helps in detecting and managing medication-induced liver issues. *ARDS* - **Acute Respiratory Distress Syndrome (ARDS)** can occur in severely ill patients, but it is not a direct or most common complication of rheumatoid arthritis nor a primary cause of death. [2] - RA can affect the lungs (e.g., interstitial lung disease), but ARDS is typically a severe, acute event triggered by other conditions like **sepsis** or trauma. *Pulmonary fibrosis* - **Interstitial lung disease (ILD)**, including pulmonary fibrosis, is a known extra-articular manifestation of RA and can be a significant cause of morbidity and mortality. [2] - However, **cardiovascular events**, particularly ischemic heart disease, still surpass pulmonary fibrosis as the leading cause of death in RA patients.
Explanation: ***Infective endocarditis*** - The abnormal blood flow and turbulent swirling within a **patent ductus arteriosus (PDA)** create an environment prone to bacterial colonization, making infective endocarditis the most common cause of death in adults with PDA. - The risk of **infective endocarditis** in adults with an untreated PDA is significant, leading to severe downstream complications. *Rupture* - While rupture is a rare complication, it is not the most common cause of death in adults with an isolated PDA, particularly when compared to infectious complications. - Rupture may be associated with other underlying cardiovascular conditions or very large PDAs, but it is not the leading cause of mortality. *Embolism* - Embolism can occur in PDA, especially paradoxical emboli in the rare event of severe pulmonary hypertension with right-to-left shunting. - However, it is less common than infective endocarditis as a primary cause of death in adults with a typical PDA. *CCF* - **Congestive cardiac failure (CCF)** is a significant complication of PDA, particularly in large shunts, leading to symptoms like dyspnea and fatigue. - While CCF can contribute to morbidity and mortality, **infective endocarditis** is generally considered the more common direct cause of death in adults with an untreated PDA.
Explanation: *Ventricular septal defect* - A **ventricular septal defect (VSD)** is one of the four cardinal features of **Tetralogy of Fallot (TOF)**, not an exclusion criterion. - The VSD in TOF is typically **large and unrestrictive**, allowing for mixing of oxygenated and deoxygenated blood. *Infundibular stenosis* - **Infundibular stenosis** (pulmonary outflow tract obstruction) is a fundamental component of TOF, causing restricted blood flow to the pulmonary artery. - The degree of **right ventricular outflow tract obstruction** is the primary determinant of the clinical severity of TOF. *Overriding of aorta* - The **overriding aorta**, where the aortic root originates above both ventricles and the VSD, is a key anatomical feature of TOF. - This position allows deoxygenated blood from the right ventricle to directly enter the **systemic circulation**. *RVH* - **Right ventricular hypertrophy (RVH)** is a compensatory response to the increased pressure load on the right ventricle due to the **pulmonary stenosis** in TOF. - This **thickening of the right ventricular muscle** is an expected and essential criterion for the diagnosis of TOF.
Explanation: ***Multiparity*** - **Multiparity** (having given birth multiple times) has no known association with **Buerger's disease**. - Buerger's disease is strongly linked to **smoking** and affects blood vessels, not reproductive states. [1] *Small veins* - **Buerger's disease** is a **thromboangiitis obliterans** that affects small and medium-sized arteries and veins. - Inflammation and thrombosis can be found in small veins, though arterial involvement is more prominent. [1] *Small arteries* - The disease primarily involves **inflammatory changes** and **thrombosis** of the **small and medium-sized arteries**. [1] - This leads to **ischemia** and potential **gangrene** in the affected extremities. *Medium-sized arteries* - **Medium-sized arteries** are characteristic sites of involvement, particularly in the **distal extremities**. - These vessels become occluded, causing pain, ulcers, and tissue loss.
Explanation: ***Echocardiography*** - **Echocardiography** is the gold standard for visualizing cardiac structures and valve function, allowing direct assessment of **mitral valve prolapse (MVP)** [1]. - The presence of **multiple ejection clicks** and a murmur in a young female with non-exertional chest pain strongly suggests MVP, which can be confirmed by echocardiography [3]. *ECG* - An **ECG** can detect arrhythmias or signs of ischemia, but it cannot directly visualize the heart valves or diagnose **mitral valve prolapse** [2]. - While some MVP patients may have T-wave abnormalities or QT prolongation, these findings are non-specific and not diagnostic. *Thallium 201 scan* - A **Thallium 201 scan** is a nuclear imaging test primarily used to assess myocardial perfusion and detect areas of ischemia, usually in the context of **coronary artery disease** [4]. - It does not provide detailed anatomical information about heart valves or cardiac chamber morphology, making it unsuitable for diagnosing **mitral valve prolapse**. *Tc pyrophosphate scan* - A **Tc pyrophosphate scan** is primarily used to diagnose **amyloidosis** or evaluate myocardial infarction, particularly for detecting late-phase complications or right ventricular involvement. - It does not offer direct visualization of valvular structures and is not indicated for the diagnosis of **mitral valve prolapse**.
Explanation: ***All of the options*** - Pulmonary stenosis refers to an obstruction of blood flow from the **right ventricle to the pulmonary artery**, which can occur at multiple levels. - The obstruction can be **valvular, subvalvular, or supravalvular**, affecting different anatomical locations within the right ventricular outflow tract and pulmonary artery. *Subvalvular* - This form of obstruction occurs **below the pulmonary valve**, often due to muscle bundles or an aberrant septal band. - An example is a **double-chambered right ventricle**, where an abnormal muscle band divides the right ventricle. *Valvular* - The most common site of pulmonary stenosis is at the **level of the pulmonary valve itself**, due to commissural fusion or dysplastic leaflets. - This leads to restricted opening of the valve, creating a pressure gradient during **systole**. *Supravalvular* - This obstruction occurs **above the pulmonary valve**, typically in the main pulmonary artery or its branches. - It can be an isolated lesion or associated with certain syndromes like **Alagille syndrome**.
Explanation: ***Cholesterol/HDL<3.5*** - The **total cholesterol to HDL ratio** is a strong predictor of cardiovascular risk, particularly in hypertensive patients, as it integrates both pro-atherogenic (total cholesterol) and anti-atherogenic (HDL) lipid fractions [1]. - A ratio of **<3.5** generally indicates a lower cardiovascular risk, while higher ratios are associated with increased risk. *Triglycerides <150mg/dL* - While high triglycerides are an independent risk factor, a level of **<150 mg/dL** is considered normal and does not provide comprehensive cardiovascular risk stratification on its own. - High triglycerides are often associated with other metabolic abnormalities, but this single value does not reflect the balance of pro- and anti-atherogenic particles as effectively as the cholesterol/HDL ratio. *LDL cholesterol <100mg/dL* - **LDL cholesterol** is a primary target for lipid-lowering therapy, and a level of **<100 mg/dL** is generally desirable for cardiovascular health [1]. - However, relying solely on LDL might miss patients with high cardiovascular risk due to low HDL or other dyslipidemias not fully captured by LDL alone [1]. *HDL <30mg%* - **Low HDL** is an independent risk factor for cardiovascular disease [1]. However, simply using a low threshold like **<30 mg%** only identifies a subset of high-risk individuals. - This parameter doesn't account for total cholesterol levels, making the **ratio of total cholesterol to HDL** a more robust and comprehensive indicator of overall lipid-related cardiovascular risk.
Explanation: ***Palpable pulses*** - Erythrocyanosis is characterized by **vasospasm** and **vasoconstriction**, yet the large arteries typically maintain patency, allowing pulses to remain palpable. - The disease primarily affects the **small cutaneous vessels**, leading to color changes and temperature abnormalities, without usually compromising the main arterial supply to the point of unpalpable pulses. *Affects young girls* - **Erythrocyanosis** (specifically chilblain lupus or perniosis) typically affects **young women** and girls, often presenting in colder climates. - Hormonal factors and a higher prevalence of **autoimmune conditions** in females may contribute to its occurrence. *Cold peripheries* - The condition is characterized by **poor peripheral circulation** and **vasoconstriction**, leading to cold extremities, especially in response to cold exposure. - This symptom is a hallmark of erythrocyanosis and differentiates it from conditions with improved warmth or arterial insufficiency. *Ulceration and gangrene of fingers* - Although erythrocyanosis involves significant microvascular dysfunction, **ulceration and gangrene are uncommon** in this condition, differentiating it from severe forms of vasculitis or Raynaud's phenomenon. - The changes are predominantly **vasospastic** and inflammatory, rather than overtly thrombotic or ischemic, which would lead to tissue loss.
Explanation: Right atrial dilatation - Ebstein anomaly is characterized by the **apical displacement** of the tricuspid valve leaflets, which incorporates a portion of the right ventricle into the right atrium, functionally increasing its size. - This **atrialization of the right ventricle** leads to significant **right atrial dilatation** as it has to handle a larger volume [1]. *Right ventricular dilatation* - While there is a functional impairment of the right ventricle due to the displaced tricuspid valve, the **working part of the right ventricle** is often small and hypoplastic, not dilated. - The "atrialized" part of the right ventricle contributes to **right atrial dilatation**, not ventricular dilatation [1]. *Left atrial dilatation* - Ebstein anomaly primarily affects the **right side of the heart**, specifically the **tricuspid valve** and right ventricle. - There is no direct anatomical or physiological mechanism in Ebstein anomaly that would typically cause **left atrial dilatation**. *Left ventricular dilatation* - Similar to left atrial dilatation, Ebstein anomaly is a **right-sided heart defect**. - **Left ventricular morphology and function** are generally preserved in Ebstein anomaly, and dilatation is not a characteristic feature.
Explanation: Cholesterol/HDL < 3.5 [1] - A total cholesterol-to-HDL ratio of less than 3.5 is considered optimal for cardiovascular risk reduction. - This ratio indicates a favorable balance, where the proportion of 'good' HDL cholesterol is relatively high compared to total cholesterol. LDL / cholesterol > 10 mg% - This option is unclear and likely misphrased, as LDL cholesterol is typically measured independently, not as a ratio to total cholesterol in this manner [1]. - Desired LDL levels are typically much lower than 100 mg/dL for high-risk individuals, and a ratio of LDL to total cholesterol greater than 0.1 (or 10%) is generally observed, but not a specific target for reduction [1]. HDL < 30 mg% - An HDL level less than 40 mg/dL (or 30 mg% for some contexts) is considered low and undesirable, as high HDL is protective against cardiovascular disease [1]. - This value would indicate increased cardiovascular risk, contrary to a desired parameter. HDL / cholesterol ratio < 3.5 - This ratio, as stated, is the inverse of the commonly used and desirable total cholesterol-to-HDL ratio. - If the HDL/cholesterol ratio were less than 3.5, it would imply a relatively low HDL compared to total cholesterol, which is an undesirable cardiovascular risk factor [1].
Coronary Artery Disease and Angina
Practice Questions
Acute Coronary Syndromes
Practice Questions
Heart Failure
Practice Questions
Cardiac Arrhythmias
Practice Questions
Valvular Heart Diseases
Practice Questions
Cardiomyopathies
Practice Questions
Pericardial Diseases
Practice Questions
Congenital Heart Disease in Adults
Practice Questions
Hypertension and Hypertensive Emergencies
Practice Questions
Pulmonary Hypertension
Practice Questions
Non-invasive Cardiac Diagnostics
Practice Questions
Preventive Cardiology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free